Advertisement

Topics

Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms

12:43 EST 15 Nov 2017 | SCRIP

FDA used its de novo pathway to clear Innovative Health Solution's NSS-2 Bridge – the first device for use in...

      

Related Stories

 

Original Article: Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms

NEXT ARTICLE

More From BioPortfolio on "Neurostimulator Is First Device Marketed To Reduce Opioid Withdrawal Symptoms"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...